Jonathan Rigby Revolo Biotherapeutics's guest appearances

Jonathan Rigby Revolo Biotherapeutics

Empowered Patient Podcast

Mark Allen

David Katz

Rosalind Picard

David Solomon

Matt Murphy

Robin Smith

Thomas Cowan

Greg Miller

Travis Mickle

Justin Miller

Sean Tucker

Matt Wilson

Chris Young

Jim Martin

Robin Zander

OwlTail

Jonathan Rigby, CEO, Revolo Biotherapeutics discusses the company's revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, with less frequent chronic dosing and without suppression of the immune system. A goal that others have not been able to reach. Revolo Bio's platform drug candidates '1805 and '1104 are in development for rheumatoid arthritis, uveitis, eosinophilic esophagitis and allergic diseases. @RevoloBio #AutoimmuneDisease #AllergicDisease #RheumatoidArthritis #Uveitis #EosinophilicEsophagitis RevoloBio.com Download the transcript here

Jonathan Rigby, CEO, Revolo Biotherapeutics discusses the company's revolutionary therapies powered to reset the immune system to achieve superior long-term remission for patients with autoimmune and allergic diseases, with less frequent chronic dosing and without suppression of the immune system. A goal that others have not been able to reach. Revolo Bio's platform drug candidates '1805 and '1104 are in development for rheumatoid arthritis, uveitis, eosinophilic esophagitis and allergic diseases. @RevoloBio #AutoimmuneDisease #AllergicDisease #RheumatoidArthritis #Uveitis #EosinophilicEsophagitis <a href="http://RevoloBio.com" rel="noopener nofollow" target="_blank">RevoloBio.com</a> <a href="http://empoweredpatientradio.com/resetting-the-immune-system-to-drive-long-term-disease-remission-in-autoimmune-and-allergic-diseases-with-jonathan-rigby-revolo-biotherapeutics-transcript" rel="noopener nofollow" target="_blank">Download the transcript here</a>

Resetting the Immune System to Drive Long-Term Disease Remission in Autoimmune and Allergic Diseases with Jonathan Rigby Revolo Biotherapeutics